TRiCares begins US IDE pivotal trial of TTVR system

TRiCares SAS has enrolled and treated the first patient in its TRICURE US IDE pivotal study of the Topaz TTVR system. The first patient was enrolled at Piedmont Heart Institute in Atlanta, Georgia, US. The trial will assess the safety and effectiveness of the TRiCares Topaz system in suitable valve replacement patients. Credit: MAD.vertise / Shutterstock.com. TRiCares SAS has enrolled and treated the first patient in its TRICURE US IDE pivotal study of the Topaz transcatheter tricuspid valve replacement (TTVR) system. It is said to be the first randomised controlled trial to directly compare an investigational TTVR device with the…

Source: Medical Device Network